F458-0237 Screening compound: 7-methyl-4-(3-methylbutyl)-1-{[(2-methylphenyl)methyl]sulfanyl}-4H,5H-[1,2,4]triazolo[4,3-a]quinazolin-5-one

F458-0237 Screening compound: 7-methyl-4-(3-methylbutyl)-1-{[(2-methylphenyl)methyl]sulfanyl}-4H,5H-[1,2,4]triazolo[4,3-a]quinazolin-5-one
F458-0237 Screening compound: 7-methyl-4-(3-methylbutyl)-1-{[(2-methylphenyl)methyl]sulfanyl}-4H,5H-[1,2,4]triazolo[4,3-a]quinazolin-5-one alternative view

Chemical Structure Depiction of ChemDiv screening compound F458-0237
7-methyl-4-(3-methylbutyl)-1-{[(2-methylphenyl)methyl]sulfanyl}-4H,5H-[1,2,4]triazolo[4,3-a]quinazolin-5-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F458-0237

Molecular Formula

C23H26N4OS (C23 H26 N4 OS)

Compound Name

7-methyl-4-(3-methylbutyl)-1-{[(2-methylphenyl)methyl]sulfanyl}-4H,5H-[1,2,4]triazolo[4,3-a]quinazolin-5-one

IUPAC name

7-methyl-4-(3-methylbutyl)-1-{[(2-methylphenyl)methyl]sulfanyl}-4H5H-[124]triazolo[43-a]quinazolin-5-one

SMILES

CC(C)CCN(c(n1-c2c3cc(C)cc2)nnc1SCc1c(C)cccc1)C3=O

InChI

InChI=1S/C23H26N4OS/c1-15(2)11-12-26-21(28)19-13-16(3)9-10-20(19)27-22(26)24-25-23(27)29-14-18-8-6-5-7-17(18)4/h5-10,13,15H,11-12,14H2,1-4H3

InChI Key

QEBRFARBELXMQW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14954967

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

406.55

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

5.907

Distribution Coefficient, logD

5.907

Water Solubility, LogSw

-5.45

Polar Surface Area

39.562

Acid Dissociation Constant (pKa)

22.71

Base Dissociation Constant (pKb)

-3.57

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

34.80

F458-0237 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Antiviral Library (67538 compounds)

Protein-Protein Interaction Library (218420 compounds)

Targeted Diversity Library (40567 compounds)

Chemokine Receptor-Targeted Library (18382 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Immune system
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F458-0237 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F458-0237?
Check Price and Availability of F458-0237, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F458-0237 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F458-0237
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F458-0237
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F458-0237 available by request